Verve Therapeutics (VERV) Year-over-year net earnings per share growth for the last 12 months

Brandmark of Verve Therapeutics Inc. (VERV)

The investment potential of Verve Therapeutics (VERV) is based on the robotic synthesis of nanoparticles for the precise creation of drugs. The quarterly EPS trend profile visualizes these processes, where the 40.10 level indicates the status of the yield parameter. Efficiency is confirmed by the development of gene editing to combat hypercholesterolemia within the massive cardiovascular disease segment, while its autonomy from macroeconomics makes the asset a reliable defensive asset.

VERV: vervetx.com Year-over-year earnings per share growth rate for the last twelve months 07/04/2022 - 08/09/2025

Analytical breakdowns for Verve Therapeutics

- share price and expert price forecast:
Summary company analytics:Verve - VERV
Flagship merchandise of vervetx.com

To minimize "value trap" risks during long-term asset ownership, it is necessary to analyze earnings per share dynamics while excluding market noise. Monitoring quarterly EPS growth rates allows for a comparison between net income trends and the progress of Verve Therapeutics (VERV) clinical trials for VERVE-101/102 and support from Eli Lilly, identifying the actual inflection points of the biotech business's fundamental value.

Competitor analysis

Regeneron Pharmaceuticals (REGN) - Year-over-year earnings per share growth for the last twelve months|IRTC: Year-over-year earnings per share growth rate for the last twelve months|LNTH (Lantheus Holdings) - Quarterly EPS earnings growth|Quarterly EPS earnings growth mineralystx.com|Year-over-year earnings per share growth for the last twelve months HeartFlow Inc (HTFL)|KMTS (Kestra Medical Technologies, Inc.) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Esperion Therapeutics ESPR|AMRN - Year-over-year net earnings per share growth for the last 12 months|Anteris Technologies Ltd - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months TNYA (tenayatherapeutics.com)|CVRX: Quarterly EPS earnings growth|Milestone Pharmaceuticals, Inc. - Year-over-year earnings per one share growth for the last 12 months|CRDL (Cardiol Therapeutics Inc) - Quarterly EPS earnings growth|HeartBeam Corporation (BEAT) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Tenax Therapeutics, Inc (TENX)|Year-over-year net earnings per share growth for the last 12 months Adagio Medical Holdings ADGM|Quarterly EPS earnings growth BCDA (BioCardia Inc.)|VTAK - Year-over-year net earnings per share growth for the last 12 months|ARCA Biopharma - Quarterly EPS earnings growth|ACST - Quarterly EPS earnings growth|Aerovate (AVTE) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months WINT (Windtree Therapeutics Inc.)